There has been a worrying shortage of some critical medicines in Mexico since the Movimiento Regeneración Nacional (Morena) government led by President Andrés Manuel López Obrador opted to centralise the medicines procurement and distribution system in 2019 with the declared objectives of reducing costs and combating corruption. The shortage has affected millions of individuals, many of whom suffer from chronic diseases and rely on these medicines to survive. The López Obrador government said that the situation would only be temporary and would be resolved once the new procurement mechanism became consolidated. However, there is growing evidence that, one year on, there is still an alarming lack of medicines, with some pointing to the centralised procurement as the source of the problem. End of preview - This article contains approximately 2065 words.
Subscribers: Log in now to read the full article
Not a Subscriber?
Choose from one of the following options